Consolidated statement of comprehensive income
|
in thousand CHF |
2025 |
2024 |
|
|
Net profit |
|
182,276 |
183,619 |
|
|
|
|
|
|
Translation differences |
|
–35 |
87 |
|
Items that may be reclassified subsequently to profit or loss |
|
–35 |
87 |
|
|
|
|
|
|
Remeasurement of net defined benefit plans |
4,278 |
–19,624 |
|
|
Income taxes from remeasurement of net defined benefit plans |
|
–748 |
3,532 |
|
Share of other comprehensive income from associates and joint ventures |
796 |
499 |
|
|
Gain / (Loss) on equity instruments at fair value through other comprehensive income |
–137,014 |
2,408 |
|
|
Income taxes from fair value measurement on equity instruments at fair value through other comprehensive income |
|
125 |
17,541 |
|
Items that will not be reclassified to profit or loss |
|
–132,563 |
4,356 |
|
Other comprehensive income/(loss) |
|
–132,598 |
4,443 |
|
|
|
|
|
|
Comprehensive income |
|
49,678 |
188,062 |
|
|
|
|
|
|
Attributable to: |
|
|
|
|
– Shareholders of Galenica Ltd. |
|
48,500 |
187,394 |
|
– Non-controlling interests |
|
1,177 |
668 |